Literature DB >> 11971013

Impaired Th2 development and increased mortality during Schistosoma mansoni infection in the absence of CD40/CD154 interaction.

Andrew S MacDonald1, Elisabeth A Patton, Anne C La Flamme, Maria I Araujo, Clive R Huxtable, Beverley Bauman, Edward J Pearce.   

Abstract

The role of CD40/CD154 interaction during infection has primarily focused on pathogens that drive inflammatory Th1 responses. In this study, we show that CD40/CD154 interaction is a fundamental requirement for Th2 response development to the parasitic helminth Schistosoma mansoni. Compared with infected wild-type mice, greatly reduced levels of Th2-associated cytokines were measured both in vitro and in vivo, and no IgE or IgG1 was detected in infected CD154(-/-) mice. In the absence of an overt Th2 response, no exaggerated Th1 response was mounted by CD154(-/-) mice. Infected CD154(-/-) mice suffered severe morbidity and mortality, even though parasitemias in wild-type and CD154(-/-) mice did not differ significantly. These data indicate that CD40/CD154 interaction is required to allow development of a Th2-dominated immune response to S. mansoni and support the view that failure to develop such a response can have fatal consequences.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11971013     DOI: 10.4049/jimmunol.168.9.4643

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  IL-4 promotes stromal cell expansion and is critical for development of a type-2, but not a type 1 immune response.

Authors:  Diana Cortes-Selva; Andrew Ready; Lisa Gibbs; Bartek Rajwa; Keke C Fairfax
Journal:  Eur J Immunol       Date:  2019-01-03       Impact factor: 5.532

2.  Dual roles of CD40 on microbial containment and the development of immunopathology in response to persistent fungal infection in the lung.

Authors:  Gwo-Hsiao Chen; John J Osterholzer; Mun Y Choe; Roderick A McDonald; Michal A Olszewski; Gary B Huffnagle; Galen B Toews
Journal:  Am J Pathol       Date:  2010-09-23       Impact factor: 4.307

3.  Dexamethasone, a drug for attenuation of Schistosoma mansoni infection morbidity.

Authors:  Alexandre dos Santos Pyrrho; Juliene Antonio Ramos; Roberto Moura Neto; Célia Santos da Silva; Henrique Leonel Lenzi; Christina Maeda Takiya; Cerli Rocha Gattass
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

Review 4.  Induction and regulation of pathogenic Th17 cell responses in schistosomiasis.

Authors:  Bridget M Larkin; Patrick M Smith; Holly E Ponichtera; Mara G Shainheit; Laura I Rutitzky; Miguel J Stadecker
Journal:  Semin Immunopathol       Date:  2012-10-25       Impact factor: 9.623

5.  In the absence of CD154, administration of interleukin-12 restores Th1 responses but not protective immunity to Schistosoma mansoni.

Authors:  James P Hewitson; Paul A Hamblin; Adrian P Mountford
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

6.  CD40 is required for the optimal induction of protective immunity to Mycobacterium avium.

Authors:  Manuela Flórido; Ana Sofia Gonçalves; M Salomé Gomes; Rui Appelberg
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

Review 7.  CD40 and the immune response to parasitic infections.

Authors:  Carlos S Subauste
Journal:  Semin Immunol       Date:  2009-07-18       Impact factor: 11.130

8.  Dendritic cells activated by an anti-inflammatory agent induce CD4(+) T helper type 2 responses without impairing CD8(+) memory and effector cytotoxic T-lymphocyte responses.

Authors:  Yang Wang; Akram A Da'Dara; Paul G Thomas; Donald A Harn
Journal:  Immunology       Date:  2009-11-16       Impact factor: 7.397

9.  Overcoming CD4 Th1 Cell Fate Restrictions to Sustain Antiviral CD8 T Cells and Control Persistent Virus Infection.

Authors:  Laura M Snell; Ivan Osokine; Douglas H Yamada; Justin Rafael De la Fuente; Heidi J Elsaesser; David G Brooks
Journal:  Cell Rep       Date:  2016-09-20       Impact factor: 9.423

10.  T follicular helper cells differentiate from Th2 cells in response to helminth antigens.

Authors:  Arielle Glatman Zaretsky; Justin J Taylor; Irah L King; Fraser A Marshall; Markus Mohrs; Edward J Pearce
Journal:  J Exp Med       Date:  2009-04-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.